UNSPSC 51286504: Novobiocin

This classification denotes an antibiotic with the molecular formula C31H36N2O11, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 17EC19951N, chemically known as novobiocin, sodium deriv. but more generally known as novobiocin, which bears US NIH Compound Identifier 4546. European Medicines Agency schedules Novobiocin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09385MIG.

The term NOVOBIOCIN is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 13, No. 12, 1959, List 3). NOVOBIOCIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: O1C(C(OC)C(OC(=O)N)C(O)C1OC1C(C2OC(O)C(NC(=O)C3CC(C/C=C(/C)C)C(O)CC3)C(=O)C2CC1)C)(C)C.

UNSPSC 51286504 Novobiocin is a Commodity code for a specific antibiotic pharmaceutical product, yet the recent state and local opportunities tagged under it do not actually involve novobiocin procurement. Instead, the tagged solicitations concern broader pharmaceutical supply contracts for unrelated drugs—doxycycline, ciprofloxacin, and naloxone—suggesting a mismatch between the code assignment and the work being solicited. State and local governments use this code to tag pharmaceutical acquisitions through cooperative purchasing vehicles and direct procurements, but the recent activity shows little genuine novobiocin demand. When novobiocin procurement does occur, it appears embedded in larger pharmaceutical warehouse or emergency-response supply contracts rather than as a standalone line item.

The Illinois Department of Public Health and Seminole County, Florida represent the issuing bodies in recent records. The Illinois procurement, awarded to Chartwell Rx LLC on August 28, 2026, supplied antibiotics through the MMCAP Infuse consortium piggyback contract with a total award of $2,999,999.11 over three years; Seminole County's June 30, 2026 IFB sought annual quantities of naloxone and drug deactivation systems for community health delivery. Neither solicitation references novobiocin specifically, and the code's recent activity is concentrated in the Southeast and Midwest. The code shows minimal relevant procurement volume under its nominal scope in the current state and local market.